Profile
SION VRTX REGN SGEN ALNY ARGX
Company Name Sionna Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $698.93M $116.96B $55.30B $43.15B $41.50B $33.66B
Employees 0.04K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Michael Cloonan Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
SION VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 1
Quant Rating Sell Sell Buy Neutral Strong Sell Strong Sell
Trading
SION VRTX REGN SGEN ALNY ARGX
Last Close $15.84 $441.3 $521 $228.74 $322.83 $560.14
High 52 $22.47 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 - $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -29.51 % -14.6 % -56.65 % 0 % -0.67 % -16.61 %
Price vs. 52 Week Low 0 % 11.26 % 7.89 % 0 % 43.75 % 30.25 %
Total Return
SION VRTX REGN SGEN ALNY ARGX
1 Month Return 15.7 % -0.17 % 6.27 % 0 % 6.02 % -2.29 %
3 Month Return 37.02 % -10.43 % -18.26 % 0 % 20.25 % -4.92 %
6 Month Return 0 % 10.5 % -25.85 % 0 % 36.79 % -9.65 %
9 Month Return 0 % -5.11 % -50.44 % 0 % 17.38 % 3.33 %
YTD Return 0 % 9.59 % -26.86 % 0 % 37.19 % -8.92 %
1 Year Return 0 % -5.85 % -50.43 % 0 % 32.85 % 30.25 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SION VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.34 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -234.12 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
SION VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -15.16 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM 297.47 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -17.64 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 88.23 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -512.75 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.83 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.84 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 1013.93 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.48 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -512.75 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -14.28 -92.97 18.31 -81.26 -550.45 -433.65
Price To Operating Cash Flows Ratio TTM -8.65 -119.36 14.06 -93.1 -914.84 -515.25
Price Cash Flow Ratio TTM -8.65 -119.36 14.06 -93.1 -914.84 -515.25
Income Statement (TTM)
SION VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.07B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.06B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -15.99 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
SION VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.01B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.35B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $-0.16B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0.13B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.01B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.19B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
SION VRTX REGN SGEN ALNY ARGX
Net Income $-0.06B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.05B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.22
AARD Aardvark Therapeutics, Inc. Common Stock 13.5
ABCL AbCellera Biologics Inc. 3.42
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.69
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.165
ABPWW 0.0207
ABSI Absci Corporation 2.57
ABUS Arbutus Biopharma Corporation 3.08
ABVC ABVC BioPharma, Inc. 2.225
ABVX Abivax SA American Depositary Shares 7.665
ACAD ACADIA Pharmaceuticals Inc. 21.58
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6143
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.25
ACIU AC Immune SA 2.02
ETFs With Exposure to SION
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 304.09
SCHB Schwab U.S. Broad Market ETF 0.000454784 23.835
SCHA Schwab U.S. Small-Cap ETF 0.00425921 25.325
VXF Vanguard Extended Market Index Fund 0 192.88
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.74 19.36
VTWV Vanguard Russell 2000 Value Index Fund 0 139
VTWG Vanguard Russell 2000 Growth Index Fund 0 208.775
VTWO Vanguard Russell 2000 Index Fund 0 87.29
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 103.17
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.88
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.87
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 145.5
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 145.51
VEMPX Vanguard Extended Market Index InstlPlus 0 359.07
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 277.06
Unlock